Experimental & Molecular Medicine, Published online: 06 November 2026; doi:10.1038/s12276-026-01884-z Cellular identity is shaped by transcription factors (TFs) that regulate gene expression through interactions with DNA elements. Recent studies have expanded the list of TFs capable of reprogramming cell fates, yet only a few have been thoroughly validated. This Review highlights the use of pluripotent stem cells as a platform to systematically compare TF activity across developmental paths, focussing on single-TF perturbation to identify lineage determinants. High-throughput screening and single-cell transcriptomics reveal that TFs can induce lineage-specific programs, but outcomes are cont
Yeejin Jang, Muyoung Lee, & Jonghwan Kim (2026). High-throughput single-transcription factor-mediated direct cell-fate engineering. Experimental & Molecular Medicine. https://doi.org/10.1038/s12276-026-01884-z
Yeejin Jang, et al. “High-throughput single-transcription factor-mediated direct cell-fate engineering.” Experimental & Molecular Medicine, 2026. doi:10.1038/s12276-026-01884-z.
@article{Jang2026,
title = {High-throughput single-transcription factor-mediated direct cell-fate engineering},
author = {Jang, Yeejin and Lee, Muyoung and Kim, Jonghwan},
journal = {Experimental \& Molecular Medicine},
year = {2026},
doi = {10.1038/s12276-026-01884-z},
url = {https://www.nature.com/articles/s12276-026-01884-z}
}
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05030-x Comment on: ‘Association of accelerometer-monitored physical activity with incident cataract: epidemiological and genetic evidence’
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05032-9 NAION during incretin-based therapy: an optic nerve head still adapted to hypertension
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05016-9 Comparing refractive errors in CACNA1F and CABP4 -associated disease in a UK cohort
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05018-7 Comment on: ‘Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease’